Berwaer
Monique Berwaer, Brussels BE
Patent application number | Description | Published |
---|---|---|
20110091547 | Pharmaceutical Compositions Comprising Brivaracetam - The present invention relates to a pharmaceutical composition comprising brivaracetam as active ingredient, the invention relates specifically to a prolonged release formulation. | 04-21-2011 |
20110250282 | Prolonged Release Formulations Comprising an 2-Oxo-1-Pyrrolidine Derivative - The present invention relates to a pharmaceutical composition comprising Levetiracetam, Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation. | 10-13-2011 |
20110274762 | Prolonged Release Formulations Comprising an 2-Oxo-1-Pyrrolidine Derivate - The present invention relates to a pharmaceutical composition comprising Brivaracetam or Seletracetam as active ingredient, the invention relates specifically to a prolonged release formulation made of granules containing the active ingredient in their inner core. | 11-10-2011 |
20110275693 | Pharmaceutical Compositions Comprising 2-Oxo-1-Pyrrolidine Derivatives - The present invention relates to an immediate release formulation of pharmaceutical compounds. | 11-10-2011 |
20110281929 | Pharmaceutical Compositions Comprising 2-Oxo-1-Pyrrolidine Derivatives - The present invention relates to an immediate release formulation of pharmaceutical compounds. | 11-17-2011 |
20120040006 | Pharmaceutical Compositions Comprising Brivaracetam - The present invention relates to a pharmaceutical composition comprising brivaracetam as active ingredient, the invention relates specifically to a prolonged release formulation. | 02-16-2012 |
Monique Berwaer, Ham-Sur-Heure-Nalinnnes BE
Patent application number | Description | Published |
---|---|---|
20110027359 | Novel Pharmaceutical Compositions Comprising Levetiracetam - The present invention relates to a pharmaceutical composition comprising levetiracetam as active ingredient, the invention relates specifically to a prolonged release formulation. | 02-03-2011 |
Monique Berwaer, Ham-Sur-Heure-Nalinnes BE
Patent application number | Description | Published |
---|---|---|
20080206331 | TABLET COMPRISING EFLETIRIZINE AND PSEUDOEPHEDRINE - The present invention concerns a tablet comprising two distinct segments. More particularly the invention relates to combinations of two pharmaceutical substances and methods of treatment of allergic disorders. | 08-28-2008 |
20090047344 | Formulations - The present invention relates to pharmaceutical compositions for oral administration of active compounds. | 02-19-2009 |
20120010218 | FORMULATIONS - The present invention relates to pharmaceutical compositions for oral administration of active compounds. | 01-12-2012 |
Monique Jenny Marie Berwaer, Manhay BE
Patent application number | Description | Published |
---|---|---|
20100152277 | DIACYLGLYCEROL ACYLTRANSFERASE ASSAY - The present invention generally provides a method of measuring the biological activity of diacylglycerol acyltransferase (DGAT). Specifically, the present invention provides a method for rapid, mass screening of compounds which are able to modulate the biological activity of DGAT. More specifically, the present invention provides an assay system for measuring DGAT activity based on the use of particular micelles with the FlashPlate™ technology. | 06-17-2010 |
20100190789 | PIPERIDINE/PIPERAZINE DERIVATIVES - The invention relates to a DGAT inhibitor of formula (I): including any stereochemically isomeric form thereof, wherein A represents CH or N; the dotted line represents an optional bond in case A represents a carbon atom; X represents —C(═O)—; —O—C(═O)—; C(═O)—C(═O)—; —NR | 07-29-2010 |
20100210618 | PIPERIDINE/PIPERAZINE DERIVATIVES - The invention relates to a DGAT inhibitor of formula (I), including any stereochemically isomeric form thereof, wherein A represents CH or N; the dotted line represents an optional bond in case A represents a carbon atom; X represents —O—C(═O)—; —C(═O)—C(═O)—; —NR | 08-19-2010 |
20150087629 | PIPERIDINE/PIPERAZINE DERIVATIVES - The invention relates to a DGAT inhibitor of formula | 03-26-2015 |